BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Nippon Chemiphar Co., Ltd. 

2-2-3 Iwamoto-cho
Chiyoda-ku
Tokyo    101  Japan
Phone: 81-3-38631211 Fax: 81-3-38645940


SEARCH JOBS




Industry
Pharmaceutical

Segment
Research





 Company News
Ranbaxy Laboratories Sells Stake in JV to its Partner Nippon Chemiphar Co., Ltd. 12/8/2009 7:54:14 AM    More...
Nippon Chemiphar Co., Ltd. And Torii Pharmaceutical Co. To Terminate Sales Tie-Up For Urinary Alkalizer 3/14/2006 2:25:14 PM    More...
Carrington Laboratories (CARN) Subsidiary Announces Research Collaboration With Nippon Chemiphar Co., Ltd. To Evaluate Delivery System For Alzheimer's Drug Candidate 2/6/2006 11:09:14 AM    More...
Ranbaxy Laboratories Consolidates Relationship With Japan JV Partner Nippon Chemiphar Co., Ltd. 11/11/2005 12:16:52 PM    More...
NeoPharm (NEOL) Announces Japanese Licensing Agreement For IL13-PE38QQR With Nippon Kayaku 10/19/2005 5:11:34 PM    More...
Nippon Chemiphar Co., Ltd. And Nihon Chouzai Co Ltd. To Form Strategic Alliance 10/19/2005 5:10:06 PM    More...
Esperion Therapeutics, Inc. (ESPR) Announces License Agreement With Nippon Chemiphar Co., Ltd. To Develop New Therapies Based On PPAR Delta Agonists 10/19/2005 5:09:40 PM    More...
Cerenis Therapeutics Announces License Agreement With Nippon Chemiphar Co., Ltd. To Develop New Therapies Based On PPAR Delta Agonists 10/19/2005 5:09:11 PM    More...
Velcura Therapeutics, Inc. And Nippon Chemiphar Co., Ltd. Announce Agreement To Develop New Drug Targeting The More Than 100 Million Individuals Suffering From Osteoporosis 10/19/2005 5:09:07 PM    More...